Cimdata Logo

Industry Summary Articles

Monday, May 02, 2022

Materialise Reports First Quarter 2022 Results

Materialise NV, a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, announced its financial results for the first quarter ended March 31, 2022.

Highlights – First Quarter 2022

  • Total revenue increased 16.3% to 52,961 kEUR compared to 45,554 kEUR for the first quarter of 2021.
  • Total deferred revenues from annual software sales and maintenance fees increased by 2,937 kEUR this quarter to 38,082 kEUR.
  • Adjusted EBITDA increased to 5,443 kEUR for the first quarter of 2022 from 5,341 kEUR for the 2021 period.
  • Net profit for the first quarter of 2022 was 127 kEUR, or 0.0 EUR per diluted share, compared to (3,642) kEUR, or (0.07) EUR per diluted share, for the 2021 period.

Executive Chairman Peter Leys commented, “While the global economy was negatively impacted by a combination of geopolitical instability and the COVID-19 pandemic, Materialise continued to perform well. After posting record numbers for 2021, all of our segments grew during the first quarter of 2022, with an aggregate revenue increase of 16% on a consolidated basis, driven by the continued recovery of Materialise Manufacturing. We are particularly pleased that our deferred revenue from annual software sales and maintenance fees increased significantly, underscoring the solid recurring sales performance of our Materialise Software and Materialise Medical segments. Moreover, our Adjusted EBITDA for the quarter was 5,443 kEUR, slightly above last year’s, and included the continued operational investments in Link3D, a developer of AM manufacturing execution systems that we acquired on January 4, 2022.”

First Quarter 2022 Results

Total revenue for the first quarter of 2022 increased 16.3% to 52,961 kEUR from 45,554 kEUR for the first quarter of 2021. Adjusted EBITDA increased to 5,443 kEUR for the first quarter of 2022 from 5,341 kEUR for the 2021 period. The Adjusted EBITDA margin (Adjusted EBITDA divided by total revenue) for the first quarter of 2022 was 10.3%, compared to 11.7% for the first quarter of 2021.

The results of Link3D have been fully consolidated with the results of our Materialise Software segment as of the beginning of this year. Revenue from Materialise Software increased 2.6% to 10,483 kEUR for the first quarter of 2022 from 10,219 kEUR for the same quarter last year. Segment EBITDA decreased, including the effect of ongoing investments in Link3D, to 1,932 kEUR from 3,429 kEUR while the segment EBITDA margin was 18.4% compared to 33.6% for the prior-year period.

Revenue from our Materialise Medical segment increased 13.0% to 18,347 kEUR for the first quarter of 2022 compared to 16,231 kEUR for the same period in 2021. Segment EBITDA amounted to 3,227 kEUR for the first quarter of 2022 compared to 4,541 kEUR while the segment EBITDA margin was 17.6% compared to 28.0% for the first quarter of 2021.

Revenue from our Materialise Manufacturing segment increased 26.2% to 24,131 kEUR for the first quarter of 2022 from 19,114 kEUR for the first quarter of 2021. Segment EBITDA increased to 2,613 kEUR from (144) kEUR while the segment EBITDA margin grew to 10.8% compared to (0.8)% for the first quarter of 2021.

Gross profit grew to 28,884 kEUR compared to 24,568 kEUR for the same period last year, while gross profit as a percentage of revenue increased to 54.5% compared to 53.9% for the first quarter of 2021.

Research and development (“R&D”), sales and marketing (“S&M”) and general and administrative (“G&A”) expenses increased, in the aggregate, 17.2% to 29,773 kEUR for the first quarter of 2022 from 25,398 kEUR for the first quarter of 2021.

Net other operating income was 938 kEUR compared to 1,120 kEUR for the first quarter of 2021.

Operating result amounted to 49 kEUR compared to 290 kEUR for the first quarter of 2021.

Net financial result was 376 kEUR compared to (4,112) kEUR for the first quarter of 2021.

The first quarter of 2022 contained income tax expenses of (298) kEUR, compared to 181 kEUR income tax income in the first quarter of 2021.

As a result of the above, net profit for the first quarter of 2022 was 127 kEUR, compared to (3,642) kEUR for the same period in 2021. Total comprehensive income for the first quarter of 2022, which includes exchange differences on translation of foreign operations, was 1,543 kEUR compared to (3,150) kEUR for the 2021 period.

At March 31, 2022, we had cash and cash equivalents of 169,610 kEUR compared to 196,028 kEUR at December 31, 2021. Gross debt amounted to 93,583 kEUR, compared to 99,107 kEUR at December 31, 2021. As a result, our net cash position (gross debt less cash and cash equivalents) was 76,027 kEUR, a decrease of 20,894 kEUR, and included the effect of our call option exercise to acquire 100% of the shares of Link3D.

Cash flow from operating activities for the first quarter of 2022 increased to 11,111 kEUR from 4,231 kEUR for the same period in 2021. Total capital expenditures for the first quarter of 2022 amounted to 3,499 kEUR.

Net shareholders’ equity at March 31, 2022 was 234,121 kEUR compared to 232,577 kEUR at December 31, 2021.

Non-IFRS Measures

Materialise uses EBITDA and Adjusted EBITDA as supplemental financial measures of its financial performance. EBITDA is calculated as net profit plus income taxes, financial expenses (less financial income), shares of profit or loss in a joint venture and depreciation and amortization. Adjusted EBITDA is determined by adding share-based compensation expenses, acquisition-related expenses of business combinations, impairments and revaluation of fair value due to business combinations to EBITDA. Management believes these non-IFRS measures to be important measures as they exclude the effects of items which primarily reflect the impact of long-term investment and financing decisions, rather than the performance of the company’s day-to-day operations. As compared to net profit, these measures are limited in that they do not reflect the periodic costs of certain capitalized tangible and intangible assets used in generating revenues in the company’s business, or the charges associated with impairments. Management evaluates such items through other financial measures such as capital expenditures and cash flow provided by operating activities. The company believes that these measurements are useful to measure a company’s ability to grow or as a valuation measurement. The company’s calculation of EBITDA and Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. EBITDA and Adjusted EBITDA should not be considered as alternatives to net profit or any other performance measure derived in accordance with IFRS. The company’s presentation of EBITDA and Adjusted EBITDA should not be construed to imply that its future results will be unaffected by unusual or non-recurring items.

Non-IFRS Measures

Materialise uses EBITDA and Adjusted EBITDA as supplemental financial measures of its financial performance. EBITDA is calculated as net profit plus income taxes, financial expenses (less financial income), shares of profit or loss in a joint venture and depreciation and amortization. Adjusted EBITDA is determined by adding share-based compensation expenses, acquisition-related expenses of business combinations, impairments and revaluation of fair value due to business combinations to EBITDA. Management believes these non-IFRS measures to be important measures as they exclude the effects of items which primarily reflect the impact of long-term investment and financing decisions, rather than the performance of the company’s day-to-day operations. As compared to net profit, these measures are limited in that they do not reflect the periodic costs of certain capitalized tangible and intangible assets used in generating revenues in the company’s business, or the charges associated with impairments. Management evaluates such items through other financial measures such as capital expenditures and cash flow provided by operating activities. The company believes that these measurements are useful to measure a company’s ability to grow or as a valuation measurement. The company’s calculation of EBITDA and Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. EBITDA and Adjusted EBITDA should not be considered as alternatives to net profit or any other performance measure derived in accordance with IFRS. The company’s presentation of EBITDA and Adjusted EBITDA should not be construed to imply that its future results will be unaffected by unusual or non-recurring items.

Exchange Rate

This document contains translations of certain euro amounts into U.S. dollars at specified rates solely for the convenience of readers. Unless otherwise noted, all translations from euros to U.S. dollars in this document were made at a rate of EUR 1.00 to USD 1.1101, the reference rate of the European Central Bank on March 31, 2022.

Conference Call and Webcast

Materialise will hold a conference call and simultaneous webcast to discuss its financial results for the first quarter of 2022 on Thursday, April 28, 2022, at 8:30 a.m. ET/2:30 p.m. CET. Company participants on the call will include Wilfried Vancraen, Founder and Chief Executive Officer; Peter Leys, Executive Chairman; and Johan Albrecht, Chief Financial Officer. A question-and-answer session will follow management’s remarks.

To access the conference call, please dial 844-469-2530 (U.S.) or 765-507-2679 (international), passcode 2437458#.
The conference call will also be broadcast live over the Internet with an accompanying slide presentation, which can be accessed on the company’s website at https://investors.materialise.com. A webcast of the conference call will be archived on the company's website for one year.

Consolidated income statements (Unaudited)

   
     
   

for the three months ended
March 31,

In '000

 

2022

 

2022

 

2021*

   

U.S.$

 

 

Revenue

 

58,792

   

52,961

   

45,554

 

Cost of Sales

 

(26,729)

   

(24,078)

   

(20,986)

 

Gross Profit

 

32,064

   

28,884

   

24,568

 

Gross profit as % of revenue

 

54.5

%

 

54.5

%

 

53.9

%

             

Research and development expenses

 

(8,675)

   

(7,814)

   

(6,536)

 

Sales and marketing expenses

 

(15,003)

   

(13,515)

   

(11,310)

 

General and administrative expenses

 

(9,373)

   

(8,444)

   

(7,552)

 

Net other operating income (expenses)

 

1,041

   

938

   

1,120

 

Operating (loss) profit

 

54

   

49

   

290

 
             

Financial expenses

 

(1,431)

   

(1,289)

   

(4,701)

 

Financial income

 

1,849

   

1,665

   

589

 

Share in loss of joint venture

 

-

   

-

   

-

 

(Loss) profit before taxes

 

472

   

425

   

(3,822)

 
             

Income Taxes (*)

 

(331)

   

(298)

   

181

 

Net (loss) profit for the period (*)

 

141

   

127

   

(3,642)

 

Net (loss) profit attributable to:

 

-

         

The owners of the parent

 

148

   

134

   

(3,642)

 

Non-controlling interest

 

(7)

   

(7)

   

-

 
             

Earning per share attributable to owners of the parent

       

Basic

 

0.00

   

0.00

   

(0.07)

 

Diluted

 

0.00

   

0.00

   

(0.07)

 
             

Weighted average basic shares outstanding

 

59,064

   

59,064

   

54,169

 

Weighted average diluted shares outstanding

 

59,102

   

59,102

   

54,169

 

(*) The year 2021 has been restated to reflect the final accounting of the business combination with RS Print.

Impact on Net profit for the period and on Income taxes is 26 k€

Consolidated statements of comprehensive income (Unaudited)

   
     
   

for the three months ended
March 31,

In 000€

 

2022

 

2022

 

2021(*)

   

U.S.$

 

 

Net profit (loss) for the period (*)

 

141

   

127

   

(3,642)

 

Other comprehensive income

           

Recycling

           

Exchange difference on translation of foreign operations

 

1,572

   

1,416

   

492

 

Non-recycling

           

Fair value adjustments through OCI - Equity instruments

 

-

   

-

   

-

 

Other comprehensive income (loss), net of taxes

 

1,572

   

1,416

   

492

 

Total comprehensive income (loss) for the year, net of taxes

 

1,713

   

1,543

   

(3,150)

 

Total comprehensive income (loss) attributable to:

           

The owners of the parent

 

1,720

   

1,549

   

(3,150)

 

Non-controlling interests

 

(7)

   

(7)

   

-

 

(*) The year 2021 has been restated to reflect the final accounting of the business combination with RS Print.

Impact on Net profit for the period is 26k€.

Consolidated statement of financial position (Unaudited)

       
         
   

As of
March 31,

 

As of
December 31,

In 000€

 

2022

 

2021

Assets

       

Non-current assets

       

Goodwill

 

43,548

 

18,726

Intangible assets

 

38,075

 

31,668

Property, plant & equipment

 

84,329

 

84,451

Right-of-Use assets

 

9,270

 

9,054

Investments in joint ventures

 

-

 

-

Deferred tax assets

 

393

 

227

Investments in convertible loans

 

3,622

 

3,560

Investments in non-listed equity instruments

 

399

 

399

Other non-current assets

 

5,404

 

7,520

Total non-current assets

 

185,040

 

155,605

Current assets

       

Inventories

 

12,720

 

11,295

Trade receivables

 

38,575

 

41,541

Other current assets

 

8,169

 

8,940

Cash and cash equivalents

 

169,610

 

196,028

Total current assets

 

229,074

 

257,803

Total assets

 

414,115

 

413,408

   

As of
March 31,

 

As of
December 31,

In 000€

 

2022

 

2021

Equity and liabilities

       

Equity

       

Share capital

 

4,489

   

4,489

 

Share premium

 

233,872

   

233,872

 

Retained earnings and other reserves

 

(4,240)

   

(5,784)

 

Equity attributable to the owners of the parent

 

234,121

   

232,577

 

Non-controlling interest

 

(6)

   

1

 

Total equity

 

234,115

   

232,578

 

Non-current liabilities

       

Loans & borrowings

 

66,759

   

72,637

 

Lease liabilities

 

5,670

   

5,268

 

Deferred tax liabilities

 

4,295

   

4,371

 

Deferred income

 

5,555

   

4,952

 

Other non-current liabilities

 

2,681

   

2,168

 

Total non-current liabilities

 

84,960

   

89,396

 

Current liabilities

       

Loans & borrowings

 

17,882

   

17,849

 

Lease liabilities

 

3,272

   

3,353

 

Trade payables

 

20,202

   

20,171

 

Tax payables

 

722

   

783

 

Deferred income

 

37,226

   

33,306

 

Other current liabilities

 

15,736

   

15,972

 

Total current liabilities

 

95,040

   

91,434

 

Total equity and liabilities

 

414,115

   

413,408

 

Consolidated statement of cash flows (Unaudited)

   
     
   

for the three months ended
March 31,

In 000€

 

2022

 

2021*

Operating activities

       

Net (loss) profit for the period (*)

 

127

   

(3,642)

 

Non-cash and operational adjustments

       

Depreciation of property plant & equipment

 

3,840

   

3,803

 

Amortization of intangible assets

 

1,602

   

1,277

 

Impairment of goodwill and intangible assets

 

-

   

-

 

Share-based payment expense

 

(48)

   

(415)

 

Loss (gain) on disposal of property, plant & equipment

 

(18)

   

(32)

 

Movement in provisions

 

2

   

-

 

Movement reserve for bad debt and slow moving inventory

 

130

   

(2)

 

Financial income

 

(1,618)

   

(589)

 

Financial expense

 

1,237

   

4,701

 

Impact of foreign currencies

 

(28)

   

18

 

Share in loss (gain) of a joint venture (equity method)

 

-

   

-

 

(Deferred) income taxes (*)

 

302

   

(181)

 

Other non-current liabilities

 

-

   

-

 

Working capital adjustments

 

5,923

   

(860)

 

Decrease (increase) in trade receivables and other receivables

 

4,506

   

(931)

 

Decrease (increase) in inventories and contracts in progress

 

(1,357)

   

(329)

 

Increase (decrease) in trade payables and other payables

 

2,774

   

400

 

Income tax paid & Interest received

 

(341)

   

153

 

Net cash flow from operating activities

 

11,111

   

4,231

 

(*) The year 2021 has been restated to reflect the final accounting of the business combination with RS Print.
Impact on Net profit for the period and on (Deferred) income taxes is 26 k€.

   

for the three months ended
March 31,

In 000€

 

2022

 

2021

Investing activities

       

Purchase of property, plant & equipment

 

(2,376)

   

(1,242)

 

Purchase of intangible assets

 

(1,123)

   

(768)

 

Proceeds from the sale of property, plant & equipment & intangible assets (net)

 

93

   

183

 

Acquisition of subsidiary (net of cash)

 

(27,414)

   

-

 

(Convertible) Loans granted

 

-

   

(1,122)

 

Other equity investments in non-listed entities

 

-

   

-

 

Net cash flow used in investing activities

 

(30,820)

   

(2,949)

 

Financing activities

       

Repayment of loans & borrowings

 

(5,969)

   

(3,918)

 

Repayment of leases

 

(881)

   

(1,066)

 

Capital increase

 

-

   

-

 

Interest paid

 

(515)

   

(536)

 

Other financial income (expense)

 

(89)

   

136

 

Net cash flow from (used in) financing activities

 

(7,452)

   

(5,384)

 

Net increase/(decrease) of cash & cash equivalents

 

(27,161)

   

(4,102)

 

Cash & Cash equivalents at the beginning of the year

 

196,028

   

111,538

 

Exchange rate differences on cash & cash equivalents

 

743

   

132

 

Cash & cash equivalents at end of the period

 

169,610

   

107,568

 

Reconciliation of Net Profit (Loss) to EBITDA and Adjusted EBITDA (Unaudited)

Reconciliation of Net Profit (Loss) to EBITDA and Adjusted EBITDA (Unaudited)

   
     
   

for the three months ended
March 31,

In 000€

 

2022

 

2021 (*)

Net profit (loss) for the period (*)

 

127

   

(3,642)

 

Income taxes (*)

 

298

   

(181)

 

Financial expenses

 

1,289

   

4,701

 

Financial income

 

(1,665)

   

(589)

 

Depreciation and amortization

 

5,442

   

5,081

 

Share in loss of joint venture

 

-

   

-

 

EBITDA

 

5,491

   

5,371

 

Share-based compensation expense (1)

 

(48)

   

(415)

 

Acquisition-related expenses of business combinations (2)

 

-

   

385

 

Adjusted EBITDA

 

5,443

   

5,341

 

(1) Share-based compensation expense represents the cost of equity-settled and share-based payments to employees.
(2) Acquisition-related expenses of business combinations represents expenses incurred in connection with the acquisition of our option to buy Link3D
(*) The year 2021 has been restated to reflect the final accounting of the business combination with RS Print.
Impact on Net profit for the period and Income taxes is 26 k€.

Segment P&L (Unaudited)

                       
                         

In 000€

 

Materialise
Software

 

Materialise
Medical

 

Materialise
Manufacturing

 

Total
segments

 

Unallocated (1)

 

Consolidated

For the three months ended March 31, 2022

                       

Revenues

 

10,483

   

18,347

   

24,131

   

52,961

   

0

   

52,961

 

Segment (adj) EBITDA

 

1,932

   

3,227

   

2,613

   

7,772

   

(2,329)

   

5,443

 

Segment (adj) EBITDA %

 

18.4

%

 

17.6

%

 

10.8

%

 

14.7

%

     

10.3

%

For the three months ended March 31, 2021

                       

Revenues

 

10,219

   

16,231

   

19,114

   

45,564

   

(11)

   

45,553

 

Segment (adj) EBITDA

 

3,429

   

4,541

   

(144)

   

7,826

   

(2,486)

   

5,341

 

Segment (adj) EBITDA %

 

33.6

%

 

28.0

%

 

-0.8

%

 

17.2

%

     

11.7

%

(1) Unallocated segment adjusted EBITDA consists of corporate research and development, corporate headquarter costs and corporate other operating income (expense), and the added share-based compensation expenses, acquisition related expenses of business combinations, impairments and fair value of business combinations that are included in Adjusted EBITDA.

Reconciliation of Net Profit (Loss) to Segment adjusted EBITDA (Unaudited)

   
     
   

for the three months ended
March 31,

In 000€

 

2022

 

2021 (*)

Net profit (loss) for the period (*)

 

127

   

(3,642)

 

Income taxes (*)

 

298

   

(181)

 

Financial cost

 

1,289

   

4,701

 

Financial income

 

(1,665)

   

(589)

 

Share in loss of joint venture

 

-

   

-

 
         

Operating (loss) profit

 

49

   

289

 
         

Depreciation and amortization

 

5,442

   

5,081

 

Corporate research and development

 

816

   

692

 

Corporate headquarter costs

 

2,106

   

2,648

 

Other operating income (expense)

 

(640)

   

(855)

 
         

Segment adjusted EBITDA

 

7,772

   

7,855

 

(*)The year 2021 has been restated to reflect the final accounting of the business combination with RS Print.

Impact on Net profit for the period and Income taxes is 26 k€.

To view the original press release, please click here.

Search for Materialise on CIMdata.com

r
ipad background image

Featured Cimdata Reports

ipadcontent
PLM-Enabled Digital Transformation Benefits Appraisal Guide

The Guide is designed to help potential PLM users evaluate the applicability and payoffs of PLM in their enterprise, and to help existing users of PLM monitor the impact it is having on their product programs.

ipadcontent
Aerospace & Defense PLM Action Group

A CIMdata administered PLM advocacy group for the A&D industry

ipadcontent
PLM Market Analysis Reports

The PLM MAR Series provides detailed information and in-depth analysis on the worldwide PLM market. It contains analyses of major trends and issues, leading PLM providers, revenue analyses for geographical regions and industry sectors, and historical and projected data on market growth.

ipadcontent
PLM Market Analysis Country Reports

These reports offer country-specific analyses of the PLM market. Their focus is on PLM investment and use in industrial markets. Reports cover Brazil, France, Germany, India, Italy, Japan, Russia, South Korea, the United Kingdom, and the United States.

ipadcontent
Simulation & Analysis Market Analysis Report

This report presents CIMdata’s overview of the global simulation and analysis market, one of the fastest growing segments of the overall product lifecycle management market, including profiles of the leading S&A firms.

ipadcontent
CAM Market Analysis Report

CIMdata's definitive guide to the worldwide CAM software and services market. This comprehensive report provides critical intelligence on market size, user expenditures, trends, and segmentation, alongside authoritative rankings of the top CAM solution providers and reseller revenues.